It’s Topical | Will new injection end HIV?

South Africa has launched Lenacapavir, a new long-acting HIV prevention injection that many believe could change the fight against HIV.

For a country that has carried one of the world’s biggest HIV burdens, this breakthrough offers new hope. But can it make a real difference, and what needs to happen to ensure everyone who needs it can access it?

This week, we discuss the promise of Lenacapavir, the challenges of rolling it out, and whether it could help South Africa move closer to ending new HIV infections.

Question of the Week: Do you think the new HIV prevention injection, Lenacapavir, can help turn the tide against the epidemic?

To discuss this we are joined by Dr Nonhlanhla Ndlovu, Deputy Director General for HIV/AIDS, TB, Women and Child Health and Yvette Raphael, advocate for the prevention of HIV in Africa.

For more news, visit sabcnews.com and #SABCNews on all Social Media platforms.